Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.
about
Oral morphine for cancer painImpact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer painTransdermal fentanyl for cancer painOral morphine for cancer painFentanyl for chronic painFentanyl for chronic painOral morphine for cancer painTransdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre studyPain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients.The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionSustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain managementStrong opioids for cancer painRandomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer painAlternative opioids to morphine in palliative care: a review of current practice and evidenceEfficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysisTransdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.Opioid rotation for cancer pain: rationale and clinical aspects.Trends in Cancer Pain Management.Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Prostate cancer pain management: EAU guidelines on pain management.Differences between opioids: pharmacological, experimental, clinical and economical perspectivesTreatment options to manage pain at the end of life.Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related painManagement of opioid-induced gastrointestinal effects in patients receiving palliative care.Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentThe management of persistent pain in older persons.Current aproach to cancer pain management: Availability and implications of different treatment options.The principles of pain management in advanced cancer.Transdermal opioids for cancer pain.Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.Anticipating and treating opioid-associated adverse effects.Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.Morphine is not the only analgesic in palliative care: literature review.Constipation: opioid antagonists in people prescribed opioidsContinuous ropivacaine infusion vs transdermal fentanyl for providing postoperative analgesia following temporomandibular joint interpositional gap arthroplasty.The role of opioids in cancer pain.Pharmacological management of transient synovitis.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.
P2860
Q24185873-DE811FAE-4E9A-4DC0-BE4A-3029FFDF9B5DQ24194524-ABC08437-4F9D-49AC-B870-AF7B41BAEDF5Q24197559-401577F1-94B7-4C3E-B63A-DF2F5448367CQ24201079-81233843-EA67-4011-827B-D45605BFF423Q24203830-CC51B4BE-6882-4DB9-B32B-EF69AACB26CDQ24242219-5FD7CFA1-DBC1-496E-BCC5-7178EFB2610BQ24243158-5D24FA11-3146-4997-B400-C4131D86AEF9Q24815550-60F83ED9-2357-45ED-8A83-16172F52C4FDQ25255339-B64FE222-9A2C-497B-ACCE-7D55D5A20070Q26851158-24245F7B-BCA0-4808-BF03-B97733C1230EQ27010907-2E0E9E3C-3D52-46D1-BB07-50166C19AE5EQ28273281-3FD93AA4-3D93-46C2-B672-F78F45FE4FDDQ28353103-B8DBF287-8642-4D2E-96DD-0F56696F9634Q28364765-33AC3966-5091-4173-8BBC-7FC162C3948AQ28365903-30158D26-EDAA-48E5-9126-69B517BFC511Q33597167-B23C944A-20AD-491F-944E-D82368B37D1FQ33632748-3F770E87-C2A5-4D7F-86B3-74FC3164CC6FQ33765787-4D07C7C1-FEC2-4354-85F1-9BE3EC833951Q33887619-28600AB3-2360-4DB5-B41D-7F1C59923016Q33973870-0D6F4349-48BB-41DF-AA3F-448AE5131D6DQ34154173-22831F83-9B4D-438C-84E0-BB10D28AE1A1Q34272502-1AE62584-C283-47B3-B11B-BDEB59C7C5E9Q34283168-30F38C87-B5D5-4B0C-A2D4-B849FF10DFCAQ34332179-16675A54-03EF-4D8B-A9E1-BCC2D3185272Q34523889-7E198042-21E1-4A86-AE32-23D783107C85Q34608990-CEAC4A66-3E29-459D-B6F7-2A2E10CF4829Q34687594-838DEEA5-735F-4E5C-8E9F-1A0BD231FF0AQ34779398-0DCF9D43-27DF-464A-AF4A-A9E788047AAEQ34883515-61BF2D33-316D-417B-B623-40ED3653A022Q34893726-C32DE1AC-2D14-492A-BF0B-CC42AE43334BQ35144597-80078265-5D6A-4329-AADC-B7F6C134542CQ35194392-3C0E6BDF-B7D2-450E-BD98-797E3CFE0095Q35648863-A42AEFA9-B09D-4446-8582-6DB4B3084776Q35685930-C701CF2D-AF6E-4219-9AC3-FDE3B8A0C971Q35770714-C764F147-F85B-4A8F-939D-BC51256454ACQ35831699-EEE16B47-EA7B-4517-AEC1-D83A2EA63D9BQ36279466-550BF117-E37B-46EB-B54B-BD87FE47F9CFQ36349593-CF7C8533-2729-43E8-88B2-6C42986611BEQ36480105-683D9097-5E1A-4F40-BC1F-E8001BBD4EEEQ36551093-53DE4B29-D51E-4CAD-94B0-EEB52B6972C1
P2860
Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@ast
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@en
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@nl
type
label
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@ast
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@en
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@nl
prefLabel
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@ast
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@en
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@nl
P1476
Transdermal fentanyl versus su ...... tanyl Comparative Trial Group.
@en
P2093
P304
P356
10.1016/S0885-3924(97)00082-1
P50
P577
1997-05-01T00:00:00Z